[Meningeal myelomatosis as an exclusive form of recurrence in a case of IgA-lambda myeloma in complete systemic remission].
Meningeal myelomatosis is an extremely rare clinical presentation generally associated to terminal states of the disease and is more frequent in the presence of peripheric plasmocytosis or leukemia of the plasmatic cells. Diagnosis requires its demonstration in the cephalorhachidian liquid and its monoclonal secretion. A case of relapse of meningeal myelomatosis in a patient with multiple IgA-lambda myeloma is presented in which the systemic disease fulfilled the criteria for complete remission.
Estellés Piera
F
F
Sección de Oncología Médica, Hospital General La Fe, Valencia.
Gómez Codina
J
J
Munárriz Gandía
B
B
Maestu Maiques
I
I
Montalar Salcedo
J
J
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001536:Bence Jones Protein / Q000652:urine; D003131:Combined Modality Therapy; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood*; D007146:Immunoglobulin lambda-Chains / Q000097:blood*; D008297:Male; D008577:Meningeal Neoplasms / Q000175:diagnosis* / Q000628:therapy; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000188:drug therapy; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000628:therapy; D012074:Remission Induction
D007070:Immunoglobulin A; D007146:Immunoglobulin lambda-Chains; D001536:Bence Jones Protein
Mielomatosis meníngea como forma exclusiva de recaída en un caso de mieloma IgA-lambda en remisión completa sistémica.